ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620077; 2) Community: the network communities that were significantly associated with the response to NSC 620077; 3) Molecule: the relationships between components within communities and NSC 620077; 4) MDR: the compounds that were significantly associated with the NSC 620077.

NSC Compound Enrichment Correlation
NSC 682996 Null 0.0352028253287042 0.28248162
NSC 684906 Null 0.0352028253287042 0.18546857
NSC 686551 Null 0.0352028253287042 0.29452675
NSC 693169 Null 0.0352028253287042 0.24709224
NSC 699934 Null 0.0352028253287042 -0.041873267
NSC 718564 Null 0.0352028253287042 -0.049124581
NSC 718781 Erlotinib hydrochloride 0.0352028253287042 -0.10866894
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0352028253287042 -0.083626201
NSC 741459 (11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 0.0352028253287042 0.10173042
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0352028253287042 0.26453629
Total:108  Current:80    [First] [Prev] [Next] [Last]